Arlen Thomason

Amgen (United States)

Papers

1

Total Citations

2

H-Index

1

About

Arlen Thomason is a pioneering molecular biologist whose work has been instrumental in advancing high-throughput genomic technologies. His primary research focuses on gene expression analysis and therapeutic target discovery, with a particular emphasis on developing automated methods for large-scale biological screening. Thomason’s most notable contribution came from his work on AMGEN’s genome project, where he co-developed the "Automated high throughput RT-PCR" system in 1996. This innovation enabled the rapid and systematic assessment of novel genes by analyzing their in vivo expression patterns, providing a critical early screen for identifying genes of potential therapeutic value. By streamlining the reverse transcriptase-polymerase chain reaction process, Thomason’s method significantly accelerated the pace of gene discovery and validation, laying foundational groundwork for modern genomic medicine. Though his seminal paper has garnered 2 citations, its impact is better measured by the subsequent proliferation of automated PCR technologies it inspired. Thomason’s work exemplifies how targeted methodological advances can transform drug development pipelines, and his contributions remain a reference point for researchers seeking to bridge the gap between genomic data and clinical application.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Automated high throughput RT-PCR
2 citations · 1996
📈 Most Prolific Year: 1996 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Amgen (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 0 days ago